Notice of Special Interest (NOSI): Administrative Supplements for NCI Division of Cancer Biology Research Programs

Funding Agency:
National Institutes of Health

The Division of Cancer Biology (DCB) at the National Cancer Institute (NCI) announces the opportunity for current Physical Sciences-Oncology Network (PS-ON), Cancer Tissue Engineering Collaborative (TEC), Cancer Systems Biology Consortium (CSBC), Patient-Derived Models of Cancer (PDMC), Metastasis Research Network (MetNet), and Cellular Cancer Biology Imaging Resource (CCBIR) awardees to apply for supplemental funding to support collaborative research projects. Collaborations can include investigators within one consortium, across consortia, or may include investigators who are not currently supported by the DCB research programs listed above. Collaborative projects must include at least one investigator not named as key personnel on the parent award. The proposed research plan must be within the overall scope of the active parent U54, U01, R37 and/or R01 award. All potential applicants are highly encouraged to contact their NCI Program Director to discuss the planned collaboration and application.

  • All requests, regardless of parent award funding mechanism, must be received by 5:00 PM local time on April 28, 2022.
  • This is a one-time announcement. Late applications will not be accepted.

NOT-CA-22-058

Agency Website

Amount Description

 

    Funding Type

    Grant

    Eligibility

    Faculty

    Category

    Engineering and Physical Sciences
    Environmental & Life Sciences
    Interdisciplinary
    Medical
    Medical - Basic Science
    Medical - Clinical Science
    Medical - Translational

    External Deadline

    April 28, 2022